SCOPUS 정보 검색 플랫폼

The Lancet Global Health

Volumn 2, Issue 10, 2014, Pages e563-e564

Rethinking the development of Ebola treatments

(1) Gupta, Rajesh a

a STANFORD UNIVERSITY (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL DEVELOPMENT PLAN; CLINICAL RESEARCH; CLINICAL STUDY; COMPUTER MODEL; DRUG APPROVAL; DRUG COST; DRUG DEVELOPMENT; DRUG INDICATION; DRUG REPOSITIONING; DRUG SCREENING; EBOLA HEMORRHAGIC FEVER; FUNDING; GOVERNMENT; NOTE; THERAPY EFFECT; TREATMENT PLANNING; HEMORRHAGIC FEVER, EBOLA; HUMAN;

ANTIVIRUS AGENT;

ANTIVIRAL AGENTS; DRUG REPOSITIONING; HEMORRHAGIC FEVER, EBOLA; HUMANS;

EID: 84907260688 PISSN: None EISSN: 2214109X Source Type: Journal
DOI: 10.1016/S2214-109X(14)70304-3 Document Type: Note

Times cited : (9)

References (11)

1
- 84906079218
- Debate erupts on repurposed drugs for Ebola
- Enserink M Debate erupts on repurposed drugs for Ebola. Science 2014, 345:718-719.
- (2014) Science , vol.345 , pp. 718-719
- Enserink, M.¹

2
- 84859169880
- Drug development: raise standards for preclinical cancer research
- Begley C, Ellis LM Drug development: raise standards for preclinical cancer research. Nature 2012, 483:531-533.
- (2012) Nature , vol.483 , pp. 531-533
- Begley, C.¹ Ellis, L.M.²

3
- 84892153139
- Clinical development success rates for investigational drugs
- Hay M, Thomas DW, Craighead JL, Economidies C, Rosenthal J Clinical development success rates for investigational drugs. Nature Biotechnol 2014, 32:40-51.
- (2014) Nature Biotechnol , vol.32 , pp. 40-51
- Hay, M.¹ Thomas, D.W.² Craighead, J.L.³ Economidies, C.⁴ Rosenthal, J.⁵

4
- 84907270361
- Editorial. New approaches for Ebola therapeutics
- Aug 24
- Editorial. New approaches for Ebola therapeutics. New York Times Aug 24, 2014.
- (2014) New York Times

5
- 84907270360
- National Academies Press, Washington, DC, (accessed Sept 5, 2014).
- Drug repurposing and repositioning: workshop summary 2014, Institute of Medicine, National Academies Press, Washington, DC, (accessed Sept 5, 2014). http://www.iom.edu/Reports/2014/Drug-Repurposing-and-Repositioning.aspx.
- (2014) Drug repurposing and repositioning: workshop summary

6
- 79960796417
- Exploiting drug-disease relationships for computational drug repositioning
- Dudley JT, Deshpande T, Butte A Exploiting drug-disease relationships for computational drug repositioning. Brief Bioinform 2011, 12:303-311.
- (2011) Brief Bioinform , vol.12 , pp. 303-311
- Dudley, J.T.¹ Deshpande, T.² Butte, A.³

7
- 84907270359
- (accessed Sept 8, 2014).
- Statement on the WHO Consultation on potential Ebola therapies and vaccines WHO, (accessed Sept 8, 2014). http://www.who.int/mediacentre/news/statements/2014/ebola-therapies-consultation/en/.
- Statement on the WHO Consultation on potential Ebola therapies and vaccines

8
- 84880544466
- FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection
- 90ra79
- Johansen LM, Brannan JM, Delos SE, et al. FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection. Sci Transl Med 2013, 190:90ra79.
- (2013) Sci Transl Med , vol.190
- Johansen, L.M.¹ Brannan, J.M.² Delos, S.E.³

9
- 84905454640
- Ebola: an opportunity for a clinical trial?
- Arie S Ebola: an opportunity for a clinical trial?. BMJ 2014, 349:g4997.
- (2014) BMJ , vol.349 , pp. g4997
- Arie, S.¹

10
- 77954887077
- Clinical trial simulation: a review
- Holford N, Ma SC, Ploeger BA Clinical trial simulation: a review. Clin Pharmacol Ther 2010, 88:166-168.
- (2010) Clin Pharmacol Ther , vol.88 , pp. 166-168
- Holford, N.¹ Ma, S.C.² Ploeger, B.A.³

11
- 84904819684
- Ebola drugs still stuck in lab
- Enserink M Ebola drugs still stuck in lab. Science 2014, 345:364-365.
- (2014) Science , vol.345 , pp. 364-365
- Enserink, M.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.